Home/Veracyte/Kevin Haas
KH

Kevin Haas

Chief Development and Technology Officer

Veracyte

Veracyte Pipeline

DrugIndicationPhase
Decipher Prostate MetastaticMetastatic Prostate CancerCommercial
TrueMRD PlatformMulti-Cancer MRD DetectionDevelopment/Clinical Trials
TrueMRD UMBRELLA TrialLung, Colorectal, Pancreatic, Sarcoma (MRD-guided therapy)Phase 3
TrueMRD TOMBOLA TrialMuscle-Invasive Bladder Cancer (MRD-guided therapy)Phase 2